Outcomes of an Optimized Workflow With PulseSelect Pulsed Field Ablation (PFA) System in Paroxysmal and Persistent Atrial Fibrillation

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 320 participants.

Also called NCT07575828

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 320 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07575828
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07575828. Allocation not applicable; no masking; primary purpose treatment. Start 2026-10 (anticipated); primary completion 2028-08 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Outcomes of an Optimized Workflow With PulseSelect Pulsed Field Ablation (PFA) System in Paroxysmal and Persistent Atrial Fibrillation
Acronym
NEXT PULSE
Condition
Paroxysmal Atrial Fibrillation (PAF)
Condition
Persistent Atrial Fibrillation
Intervention (Device)
PulseSelect Pulse Field Ablation (PFA) System
Lead sponsor
Medtronic Cardiac Ablation Solutions (class: industry)

Record details

Record id
cardio:ct-nct07575828
Content hash
d76cf112ca6339afc2294ca7f74ada4aa680bffbd7092c73ce24302776d611e6